A Dutch study showed that organ-rejection drug cyclosporine significantly increased the risk of cancer in patients younger than 50 who had a liver transplant between 1986 and 2007, particularly those who more recently underwent the procedure. Researchers also found that cyclosporine treatment was more likely than standard therapy tacrolimus to result in a more aggressive type of cancer.

Full Story:
HealthDay News

Related Summaries